Search Results

There are 11994 results for: content related to: Response to a selective COX-2 inhibitor in patients with urticaria/angioedema induced by nonsteroidal anti-inflammatory drugs

  1. Pharmacokinetics of Etoricoxib in Patients with Renal Impairment

    The Journal of Clinical Pharmacology

    Volume 44, Issue 1, January 2004, Pages: 48–58, Dr Nancy G. B. Agrawal, Ms Catherine Z. Matthews, Mr Ralph S. Mazenko, Mr Walter F. Kline, Dr Eric J. Woolf, Dr Arturo G. Porras, Ms Leslie A. Geer, Ms Peggy H. Wong, Dr Meehung Cho, Ms Josee Cote, Dr Thomas C. Marbury, Dr Jack W. Moncrief, Dr Harry Alcorn Jr., Dr Suzanne Swan, Dr Marshall R. Sack, Dr Richard A. Robson, Dr Kevin J. Petty, Dr Jules I. Schwartz and Dr Keith M. Gottesdiener

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270003260338

  2. You have free access to this content
    2015 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 67, Issue S10, October 2015, Pages: 1–4046,

    Version of Record online : 5 NOV 2015, DOI: 10.1002/art.39448

  3. Pharmacokinetics of Etoricoxib in Patients with Hepatic Impairment

    The Journal of Clinical Pharmacology

    Volume 43, Issue 10, October 2003, Pages: 1136–1148, Dr. Nancy G. B. Agrawal, Dr. Mark J. Rose, Ms. Catherine Z. Matthews, Dr. Eric J. Woolf, Dr. Arturo G. Porras, Dr. Leslie A. Geer, Mr. Patrick J. Larson, Ms. Josee Cote, Ms. Stacy C. Dilzer, Dr. Kenneth C. Lasseter, Dr. Imtiaz Alam, Dr. Kevin J. Petty and Dr. Keith M. Gottesdiener

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270003257219

  4. The Effects of Modifying In Vivo Cytochrome P450 3A (CYP3A) Activity on Etoricoxib Pharmacokinetics and of Etoricoxib Administration on CYP3A Activity

    The Journal of Clinical Pharmacology

    Volume 44, Issue 10, October 2004, Pages: 1125–1131, Dr Nancy G. B. Agrawal, Ms Catherine Z. Matthews, Mr Ralph S. Mazenko, Dr Eric J. Woolf, Dr Arturo G. Porras, Dr Xun Chen, Ms Jutta L. Miller, Ms Nicole Michiels, Dr Martin Wehling, Dr Armin Schultz, Dr Alice B. Gottlieb, Dr Walter K. Kraft, Dr Howard E. Greenberg, Dr Scott A. Waldman, Dr Sean P. Curtis and Dr Keith M. Gottesdiener

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270004268129

  5. You have free access to this content
    POSTER SESSIONS

    Allergy

    Volume 63, Issue s88, June 2008, Pages: 158–611,

    Version of Record online : 27 MAY 2008, DOI: 10.1111/j.1398-9995.2008.01760.x

  6. You have free access to this content
    Poster Sessions

    Allergy

    Volume 64, Issue s90, June 2009, Pages: 179–538,

    Version of Record online : 18 MAY 2009, DOI: 10.1111/j.1398-9995.2009.02076.x

  7. Single- and Multiple-Dose Pharmacokinetics of Etoricoxib, a Selective Inhibitor of Cyclooxygenase-2, in Man

    The Journal of Clinical Pharmacology

    Volume 43, Issue 3, March 2003, Pages: 268–276, Dr. Nancy G. B. Agrawal, Dr. Arturo G. Porras, Dr. Catherine Z. Matthews, Dr. Mark J. Rose, Dr. Eric J. Woolf, Dr. Bret J. Musser, Ms. Andrea L. Dynder, Ms. Katherine E. Mazina, Dr. Kenneth C. Lasseter, Dr. Thomas L. Hunt, Dr. Jules I. Schwartz, Dr. Jacqueline B. McCrea and Dr. Keith M. Gottesdiener

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270003251122

  8. Examination of the Effect of Increasing Doses of Etoricoxib on Oral Methotrexate Pharmacokinetics in Patients With Rheumatoid Arthritis

    The Journal of Clinical Pharmacology

    Volume 49, Issue 10, October 2009, Pages: 1202–1209, Dr Jules I. Schwartz, Dr Nancy G. B. Agrawal, Dr P. H. Wong, Ms Jutta Miller, Dr Kenneth Bachmann, Dr Thomas Marbury, Dr David Hoelscher, Dr Paul F. Cavanaugh Jr and Dr Keith Gottesdiener

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009338939

  9. Characterization of Etoricoxib, a Novel, Selective COX-2 Inhibitor

    The Journal of Clinical Pharmacology

    Volume 43, Issue 6, June 2003, Pages: 573–585, Ms Aimee Dallob, Dr Christopher J. Hawkey, Dr Howard Greenberg, Mr Nicholas Wight, Dr Paul De Schepper, Dr Scott Waldman, Ms Peggy Wong, Dr Lisa DeTora, Dr Barry Gertz, Dr Nancy Agrawal, Dr John Wagner and Dr Keith Gottesdiener

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270003253703

  10. Safety of Etoricoxib, Celecoxib, and Nonselective Nonsteroidal Antiinflammatory Drugs in Ankylosing Spondylitis and Other Spondyloarthritis Patients: A Swedish National Population-Based Cohort Study

    Arthritis Care & Research

    Volume 67, Issue 8, August 2015, Pages: 1137–1149, L. E. Kristensen, A. K. Jakobsen, J. Askling, F. Nilsson and L. T. H. Jacobsson

    Version of Record online : 26 JUL 2015, DOI: 10.1002/acr.22555

  11. Nonsteroidal anti-inflammatory drugs for dysmenorrhoea

    Intervention Review

    The Cochrane Library

    Jane Marjoribanks, Reuben Olugbenga Ayeleke, Cindy Farquhar and Michelle Proctor

    Published Online : 30 JUL 2015, DOI: 10.1002/14651858.CD001751.pub3

  12. The Effect of Etoricoxib on the Pharmacokinetics of Oral Contraceptives in Healthy Participants

    The Journal of Clinical Pharmacology

    Volume 49, Issue 7, July 2009, Pages: 807–815, Dr Jules Schwartz, Dr Thomas Hunt, Dr William B. Smith, Dr Peggy Wong, Mr Patrick Larson, Ms Tami Crumley, Mr Anish Mehta, Dr Keith Gottesdiener and Dr Nancy Agrawal

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009337131

  13. Tolerance to COX-2 inhibitors in children with hypersensitivity to nonsteroidal anti-inflammatory drugs

    British Journal of Dermatology

    Volume 170, Issue 3, March 2014, Pages: 725–729, J.L. Corzo, M.A. Zambonino, C. Muñoz, C. Mayorga, G. Requena, A. Urda, C. Gallego, M. Blanca and M.J. Torres

    Version of Record online : 12 MAR 2014, DOI: 10.1111/bjd.12674

  14. INFECTION-RELATED RHEUMATIC DISEASES

    APLAR Journal of Rheumatology

    Volume 9, Issue s1, August 2006, Pages: A80–A83,

    Version of Record online : 6 JUL 2006, DOI: 10.1111/j.1479-8077.2006.00199_14.x

  15. An update of fixed drug eruptions in Singapore

    Journal of the European Academy of Dermatology and Venereology

    Volume 29, Issue 8, August 2015, Pages: 1539–1544, Y.K. Heng, Y.W. Yew, D.S.Y. Lim and Y.L. Lim

    Version of Record online : 10 DEC 2014, DOI: 10.1111/jdv.12919

  16. CELL RECEPTOR-LIGAND INTERACTION, SIGNALING AND ACTIVATION

    APLAR Journal of Rheumatology

    Volume 9, Issue s1, August 2006, Page: A39,

    Version of Record online : 6 JUL 2006, DOI: 10.1111/j.1479-8077.2006.00199_6.x

  17. Effects of Etoricoxib and Comparator Nonsteroidal Anti-Inflammatory Drugs on Urinary Sodium Excretion, Blood Pressure, and Other Renal Function Indicators in Elderly Subjects Consuming a Controlled Sodium Diet

    The Journal of Clinical Pharmacology

    Volume 47, Issue 12, December 2007, Pages: 1521–1531, Dr Jule I. Schwartz, Dr Chau Thach, Dr Kennet C. Lasseter, Dr Jutta Miller, Dr David Hreniuk, Dr Debora A. Hilliard, Dr Kare M. Snyder, Dr Barr J. Gertz and Dr Keit M. Gottesdiener

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270007307878

  18. Comparative Inhibitory Activity of Etoricoxib, Celecoxib, and Diclofenac on COX-2 Versus COX-1 in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 48, Issue 6, June 2008, Pages: 745–754, Dr Jules I. Schwartz, Dr Aimee L. Dallob, Mr Patrick J. Larson, Dr Omar F. Laterza, Ms Jutta Miller, Dr Jane Royalty, Ms Karen M. Snyder, Mr Derek L. Chappell, Ms Deborah A. Hilliard, Ms Mary E. Flynn, Dr Paul F. Cavanaugh Jr and Dr John A. Wagner

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270008317590

  19. RHEUMATOID ARTHRITIS – CLINICAL ASPECTS

    APLAR Journal of Rheumatology

    Volume 9, Issue s1, August 2006, Pages: A167–A188,

    Version of Record online : 6 JUL 2006, DOI: 10.1111/j.1479-8077.2006.00199_23.x

  20. EPIDEMIOLOGY OF RHEUMATIC DISEASES

    APLAR Journal of Rheumatology

    Volume 9, Issue s1, August 2006, Pages: A54–A66,

    Version of Record online : 6 JUL 2006, DOI: 10.1111/j.1479-8077.2006.00199_10.x